Today, shares of Knight Therapeutics Inc opened at $5.76 and closed at $5.77. It traded at a low of $5.70 to a high of $5.82.

Shares advanced 0.17% from the previous day's close of $5.76.

Today across North America, the TSX Composite closed -0.73% at 21740.20, the S&P 500 closed -1.20% at 5061.82, the Dow Jones Industrial Average closed -0.65% at 37735.11 and the Nasdaq Composite closed -1.79% at 15885.02.

Knight Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker GUD.

A total of 56,114 shares was traded during the last trading day, with total trades of 243. On average, Knight Therapeutics Inc has traded 87,241 shares in the last five days and 76,329 year-to-date.

The TSX market on the whole today saw 1,840 price advancers against 3,375 declines and 112 unchanged.

During the prior 52 weeks, GUD.TO has traded as high as $5.95 (April 11,2024) and low as $4.35 (October 23,2023). Moreover, in the last 12 months, Knight Therapeutics Inc's shares have boosted 19.96%, while they have advanced 11.18% year-to-date.

Following today's trading, Knight Therapeutics Inc has a market capitalization of $582.74 million on a float of 101,170 shares outstanding. Its annual EPS is $-0.16.

Knight Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Montreal, CAN.

Knight Therapeutics Inc's average recommendation is "Moderate Buy" based on 4.00 analysts according to Zacks. Currently, there are 3 buy ratings and 1 hold ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..